Data / Form D filings / Pulmatrix, Inc.
Pulmatrix, Inc.: Form D filings
Pulmatrix, Inc., a biotechnology company in Framingham, MA, filed 14 Form D notices with the SEC between 2015 and 2026. The latest, on April 15, 2026, reports $1 million sold of a $1 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 945 CONCORD STREET SUITE 1217, Framingham, MA, 01701
- Phone
- (888) 355-4440
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1574235
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 15, 2026 | New notice | $1,000,000 | $1,000,000 | 1 | Mar 26, 2026 | sec.gov | |
| Jul 20, 2021 | New notice | $19,629,373 | $45,000 | $19,584,373 | 5 | Jul 9, 2020 | sec.gov |
| Feb 23, 2021 | New notice | $3,250,000 | $0 | $3,250,000 | 5 | Feb 16, 2021 | sec.gov |
| Jul 20, 2020 | New notice | $19,629,373 | $0 | $19,629,373 | 5 | Jul 9, 2020 | sec.gov |
| Apr 24, 2020 | New notice | $8,070,723 | $8,070,723 | 3 | Apr 16, 2020 | sec.gov | |
| Feb 14, 2019 | New notice | $2,489,820 | $2,489,820 | 7 | Feb 12, 2019 | sec.gov | |
| Feb 14, 2019 | New notice | $73,531 | $73,531 | 1 | Feb 4, 2019 | sec.gov | |
| Feb 14, 2019 | New notice | $21,565 | $21,565 | 1 | Jan 31, 2019 | sec.gov | |
| Dec 18, 2018 | New notice | $3,656,250 | $3,656,250 | 1 | Dec 3, 2018 | sec.gov | |
| Jun 30, 2015 | New notice | $45,468,112 | $21,383,416 | $24,084,696 | 12 | Jun 15, 2015 | sec.gov |
| Jun 30, 2015 | New notice | $935,000 | $935,000 | 1 | Jun 15, 2015 | sec.gov | |
| Jun 30, 2015 | New notice | $687,500 | $687,500 | 3 | Jun 15, 2015 | sec.gov | |
| Jun 30, 2015 | New notice | $210,003 | $0 | $210,003 | 1 | Jun 15, 2015 | sec.gov |
| Jun 16, 2015 | New notice | $2,608,526 | $2,608,276 | $250 | 34 | Jun 1, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael Higgins | Director | |
| Todd Bazemore | Director | |
| Richard Batycky | Director | |
| Christopher Cabell | Director | |
| Anand Varadan | Director | |
| Peter Ludlum | Executive Officer | Interim CEO; Interim CFO |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Apr 13, 2026 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Pulmatrix, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.